Risk factors and prognostic role of renal adverse event in patients receiving immune checkpoint inhibitor therapy: analysis of data from a retrospective cohort study

BACKGROUND: Along with the widespread use of immune checkpoint inhibitors (ICIs), there has been a surge in immune-related adverse events which can limit the efficacy of ICIs. However, to date, there is a paucity of reports on renal adverse events (RAEs) related to ICIs. Therefore, this study report...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Zhiyao, Luo, Lifeng, Xu, Tian, Yang, Jin, Lv, Mengchen, Ni, Lei, Sun, Xianwen, Chen, Wei, Zhou, Lin, Wang, Xiaofei, Xiang, Yi, Gao, Beili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577783/
https://www.ncbi.nlm.nih.gov/pubmed/36267724
http://dx.doi.org/10.21037/atm-22-3684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577783/
https://www.ncbi.nlm.nih.gov/pubmed/36267724
http://dx.doi.org/10.21037/atm-22-3684

Ejemplares similares